You haven't searched anything yet.
If you are a Jazz employee please apply via the Internal Career site
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharmaceuticals.com and follow @JazzPharma on Twitter.
Brief Description:
The Late Development Team Lead (LDTL) is a critical role in the organization that has a significant impact on the late product lifecycle of a product or platform of products. The LDTL is accountable for leading the Late Development Team (LDT) in establishing and executing on a global product(s) strategy, which integrates scientific rationale, clinical development, nonclinical development, regulatory, medical, commercial input, CMC, legal and other business strategies.
The LDTL provides strategic and operational leadership to one or more LDT(s) to progress and de-risk the product from proof of concept (POC) to approval, aligned with the Target Product Profile. The LDTL serves as the single point of accountability for the product. To be successful, the LDTL must balance a focus on deep science and innovation, with speed and potential program and regulatory uncertainty or risks as well as maximizing over value for our patients. The LDTL partners with functional area leaders to ensure that the LDT has necessary resources and capabilities to execute on the approved integrated product development plan. The LDTL is responsible for representing the product strategy at Jazz governance reviews.
For certain programs, an alliance may be established with a 3rd party. In such cases, the LDTL shall establish a collaborative, empowering relationship with the 3rd party to enable effective facilitation and coordination. Awareness of cultural and organizational matters associated with the 3rd parties is also important including working with Jazz Alliance Management.
Preferred qualifications for this position include:
A strong executive with superior cross-functional leadership and collaboration skills, highly effective influencing skills, and the ability to operate across multiple geographies. A strong scientific understanding is essential, and candidates will also have proven experience leading a program or function in late-stage drug development, preferably a highly complex and/or high priority project where risk and program speed and value had to be balanced. Success in this critical role will provide the opportunity for significant professional growth.
Essential Functions
Required Knowledge, Skills, and Abilities
Required/Preferred Education and Licenses
Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.
FOR US-BASED CANDIDATES ONLY
Jazz Pharmaceuticals, Inc. is committed to fair and equitable compensation practices and we strive to provide employees with total compensation packages that are market competitive.
For this role, the full and complete base pay range is $0-$0. Individual compensation paid within this range will depend on many factors, including qualifications, skills, relevant experience, job knowledge, and other pertinent factors. The goal is to ensure fair and competitive compensation aligned with the candidate's expertise and contributions, within the established pay framework and our Total Compensation philosophy. Internal equity considerations will also influence individual base pay decisions. This range will be reviewed on a regular basis.
At Jazz, your base pay is only one part of your total compensation package. The successful candidate may also be eligible for a discretionary annual cash bonus or incentive compensation (depending on the role), in accordance with the terms of the Company's Global Cash Bonus Plan or Incentive Compensation Plan, as well as discretionary equity grants in accordance with Jazz's Long Term Equity Incentive Plan.
The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, 401k retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: https://careers.jazzpharma.com/benefits
Full Time
$339k-472k (estimate)
05/05/2024
05/20/2024
jazzpharma.com
PALO ALTO, CA
500 - 1,000
2003
Private
BRUCE C COZADD
$1B - $3B
Pharmaceutical